KOBO BIOTECH LIMITED (KOBO)

BSE: ₹4.76
Stock Performance
Corporate Announcements
Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal

Spacific features and deatils pf the resolution Plan as apprpved by the NCLT

2026-05-13 11:11:25
Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal

Approval of Resolution Plan and receipt of Order from NCLT

2026-05-11 19:33:44
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance certificate under Reg. 74(5) of SEBI (DP) for the quarter ended 31.03.2026

2026-04-15 12:26:17
Intimation Regarding Non-Applicability Of Large Entity Disclosure

Intimation Regarding Non Applicability of Large Entity Disclosure

2026-04-15 11:51:33
Closure of Trading Window

Intimatioin for Closure of Trading Window for Financial Resilt for March 31,2026

2026-03-30 16:32:29
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Submission of certificate under Reg. 74(5) of SEBI (DP) 30.06.2024

2026-02-11 11:56:07
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Submission of certificate under Reg. 74(5) of SEBI (DP) 30.09.2024

2026-02-11 11:54:33
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Submission of Certificate under Reg. 74(5) of SEBI (DP) for 31.12.2024

2026-02-11 11:52:25
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Submission of certificate under Reg. 74(5) of SEBI (DP) for 31.03.2025

2026-02-11 11:50:41
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg. 74(5) of SEBI (DP) for the quarter ended 31122025

2026-02-04 13:07:12

Quarterly Financials

Consolidated Standalone
Particulars Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
Revenue from Operations 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
YOY Revenue Growth % - - - - - - - - - - - -
Other Income 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.02
Total Income 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.02
Total Expenses + 1.86 1.35 10.42 1.48 1.10 1.19 1.79 1.24 1.22 1.23 1.26 1.35
Cost of Materials Consumed 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expense 0.49 0.11 0.06 0.05 0.06 0.06 0.06 0.06 0.06 0.07 0.07 0.07
Other Expenses 0.21 0.20 9.18 0.28 0.15 0.11 0.73 0.17 0.14 0.14 0.18 0.28
Operating Profit -1.86 -1.35 -10.42 -1.48 -1.10 -1.19 -1.79 -1.24 -1.22 -1.23 -1.26 -1.35
OPM % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Profit Before Tax + -1.86 -1.35 -10.42 -1.47 -1.10 -1.19 -1.79 -1.23 -1.22 -1.23 -1.26 -1.33
Tax Expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax % - - - - - - - - - - - -
Profit After Tax -1.86 -1.35 -10.42 -1.47 -1.10 -1.19 -1.79 -1.23 -1.22 -1.23 -1.26 -1.33
EPS (Basic) -0.78 -0.57 -4.37 -0.62 -0.46 -0.50 -0.75 0.00 0.00 -0.52 -0.53 0.00

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 0.00 0.00 0.00 0.00 0.00 0.00
YOY Revenue Growth % - - - - - -
Other Income 0.02 0.02 0.02 0.04 0.03 0.03
Total Income 0.02 0.02 0.02 0.04 0.03 0.03
Total Expenses + 4.94 5.57 15.24 19.27 21.04 22.31
Employee Benefit Expense 0.00 0.23 0.72 1.39 1.80 2.08
Other Expenses 0.62 1.27 9.79 1.40 -1.11 -0.36
Operating Profit -4.94 -5.57 -15.24 -19.27 -21.04 -22.31
OPM % 0% 0% 0% 0% 0% 0%
Profit Before Exceptional -4.93 -5.55 -15.23 -19.23 -21.01 -22.27
Exceptional Items 0.00 0.00 0.00 0.00 0.00 -2.18
Profit Before Tax + -4.93 -5.55 -15.23 -19.23 -21.01 -24.46
Tax Expense 0.00 0.00 0.00 0.00 0.00 0.00
Tax % - - - - - -
Profit After Tax -4.93 -5.55 -15.23 -19.23 -21.01 -24.46
EPS (Basic) -2.33 -2.33 -6.39 -8.07 -8.82 -10.27

Balance Sheet

Particulars Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 33.52 37.59 41.66 71.36 76.99 82.87
Property, Plant & Equipment 33.52 37.59 41.66 56.91 62.54 68.42
Capital Work in Progress 0.00 0.00 0.00 2.25 2.25 2.25
Non-Current Investments 0.00 0.00 0.00 12.19 12.19 12.19
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 37.88 37.74 37.53 159.23 159.34 156.58
Inventories 18.04 18.04 18.04 53.28 53.28 53.28
Trade Receivables 11.97 11.95 11.80 92.47 93.29 90.61
Cash and Cash Equivalents 0.14 0.08 0.08 1.52 0.09 0.09
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity -132.91 -127.98 -122.43 -107.20 -87.97 -66.96
Equity Share Capital 23.83 23.83 23.83 23.83 23.83 23.83
Other Equity -156.74 -151.81 -146.25 -131.03 -111.80 -90.79
Non-Current Liabilities 36.48 37.43 38.30 38.63 40.03 40.03
Current Liabilities 167.82 165.88 163.31 299.16 284.27 266.38
Total Liabilities 204.30 203.31 201.61 337.79 324.31 306.41

Cash Flow Statement

Particulars Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 0.20 0.87 93.76 13.67 0.00 0.00
Cash from Investing Activities 0.00 0.00 25.09 0.00 0.00 0.00
Cash from Financing Activities -0.15 -0.87 -120.28 -12.24 0.00 0.00
Net Increase/Decrease in Cash 0.05 0.00 -1.43 1.43 0.00 0.00